Background: Autism spectrum disorder (ASD) is characterized by impairments in social interaction and communication, restricted patterns of behavior, and unusual sensory sensitivities. Symptoms of autism occur in some infants, while some children are diagnosed in 2-3 years. There was a direct and indirect relationship between the dental caries and the physical growth among children. The study purpose was to determine the oral health and the body growth status among children with Autism spectrum disorder. Methods: The study population consisted of 53 children, who were diagnosed as “ASD” and approved by psychiatrist between the age of 3-18. The dental examination was done under recommendation by WHO (2013) and oral hygiene index was calculated by FedorovVolodkina (1973). Body growth status was evaluated by Kaup and Rohrer’s index. The results of the study were processed using statistical Stata-21 software. Results: The prevalence of dental caries among all children with Autism spectrum disorder was 88.6% and mean DMFT score were 2.6±3.0 in the primary dentition, 6.1±3.8 in the mixed and 4.0±2.3 in the permanent dentition. Children with good oral hygiene index were 32% of all study population and poor were 68%. When we assessed the body growth status, normal weight children were 52.8%, overweight children were 18.9% and lower weight was 28.3% of all study poptulation. Conclusion We have found that the oral health and the body growth status among children with ASD were poor.

Background: From the perspective of traditional medicine, researchers believe that the individual’s innate quality has a reciprocal effect on the physiological level. The study of body-specific quality differences is important for improving disease risk prediction, diagnosis, and treatment approaches. Therefore, explaining the features of traditional medicine with some physiological parameters and establishing the relationship between them is clinically significant and important for predicting disease risk and developing individualized treatment methods, which is the basis of this research. Aim: To establish the correlation between an individual’s innate unique constitution and specific biochemical indicators. Materials and Methods: The innate unique constitution of individuals was determined using electronic data, and the relationships between their characteristics and levels of uric acid, creatinine, urea, and glucose in the blood were analyzed. Results: A total of 102 participants were included in the study. Among them, the Shar-Khi constitution was the most prevalent, with 28 cases (27.45%), while the Khi-Badgan constitution was the least common, with 13 cases (12.75%). Individuals with the Khi-Shar constitution exhibited the highest urea level at 4.47 ммоль/л, whereas those with the Badgan-Shar constitution had the lowest at 4.15 ммоль/л. The uric acid level was highest in individuals with the Shar-Khi constitution at 316.15 µmol/L and lowest in those with the Badgan-Shar constitution at 261.36 µmol/L (p<0.001). Furthermore, individuals with the Badgan-Khi constitution had the highest creatinine level at 73.51 µmol/L, while those with the Badgan-Shar constitution had the lowest at 63.97 µmol/L (p<0.001). The blood glucose level was highest in individuals with the Khi-Badgan constitution at 4.59 ммоль/л and lowest in those with the Khi-Shar constitution at 4.21 ммоль/л. Kidney function indicators, particularly creatinine, significantly correlated with blood glucose levels (r=0.67, p<0.01). Higher uric acid and creatinine levels were associated with elevated blood glucose levels. These findings suggest that variations in urea, uric acid, and creatinine levels among different unique constitutions could be utilized to predict the risk of kidney disease or diabetes. Conclusion Depending on the individual characteristics of traditional medicine, kidney and blood sugar parameters are different and related to each other, and can assess the state of diabetes and kidney disease. Determining the inherent characteristics of an individual is considered important for improving the diagnosis, treatment, and prevention of diabetes and kidney disease.